Main > ONCOLOGY (**) > TGCT > TREAT.: > Co: JP. D. Pexidartinib Capsules

---

Co: JP. D. Pexidartinib Capsules's subsections
(*) USA Approval Date: 2019. 08.05.
Also Called: GCT-TS; PVNS
Company
Mechanism: CSF1R Inhibition
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 22
Patent>UpDate: 2019. 11.26.
TradeMark
TradeMark Web-Site

Co: JP. D. Pexidartinib Capsules's products
This section has no products